Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Miners, JO' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bowalgaha, K; Miners, JO
      The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    2. Court, MH; Duan, SX; Von Moltke, LL; Greenblatt, DJ; Patten, CJ; Miners, JO; Mackenzie, PI
      Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Mackenzie, PI; Miners, JO; McKinnon, RA
      Polymorphisms in UDP glucuronosyltransferase genes: Functional consequences and clinical relevance

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    4. Bhasker, CR; McKinnon, W; Stone, A; Lo, ACT; Kubota, T; Ishizaki, T; Miners, JO
      Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance

      PHARMACOGENETICS
    5. Miners, JO; Coulter, S; Birkett, DJ; Goldstein, JA
      Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

      PHARMACOGENETICS
    6. Ong, CE; Coulter, S; Birkett, DJ; Bhasker, CR; Miners, JO
      The xenobiotic inhibitor profile of cytochrome P4502C8

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. McLure, JA; Miners, JO; Birkett, DJ
      Nonspecific binding of drugs to human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    8. Gates, S; Miners, JO
      Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    9. MINERS JO; BIRKETT DJ
      CYTOCHROME P4502C9 - AN ENZYME OF MAJOR IMPORTANCE IN HUMAN DRUG-METABOLISM

      British journal of clinical pharmacology
    10. TASSANEEYAKUL W; BIRKETT DL; MINERS JO
      INHIBITION OF HUMAN HEPATIC CYTOCHROME P4502E1 BY AZOLE ANTIFUNGALS, CNS-ACTIVE DRUGS AND NONSTEROIDAL ANTIINFLAMMATORY AGENTS

      Xenobiotica
    11. ONG CE; MINERS JO; BIRKETT DJ; BHASKER CR
      BACULOVIRUS-MEDIATED EXPRESSION OF CYTOCHROME P4502C8 AND HUMAN NADPH-CYTOCHROME P450 REDUCTASE - OPTIMIZATION OF PROTEIN EXPRESSION

      Xenobiotica
    12. BHASKER CR; MINERS JO; COULTER S; BIRKETT DJ
      ALLELIC AND FUNCTIONAL VARIABILITY OF CYTOCHROME P4502C9

      Pharmacogenetics
    13. BHASKER CR; MINERS JO; COULTER S; BIRKETT DJ
      ALLELIC AND FUNCTIONAL VARIABILITY OF CYTOCHROME P4502C9

      Pharmacogenetics
    14. ZHANG H; COVILLE PF; WALKER RJ; MINERS JO; BIRKETT DJ; WANWIMOLRUK S
      EVIDENCE FOR INVOLVEMENT OF HUMAN CYP3A IN THE 3-HYDROXYLATION OF QUININE

      British journal of clinical pharmacology
    15. BIRKETT DJ; MINERS JO; VALENTE L; LILLYWHITE KJ; DAY RO
      1-METHYLXANTHINE DERIVED FROM CAFFEINE AS A PHARMACODYNAMIC PROBE OF OXYPURINOL EFFECT

      British journal of clinical pharmacology
    16. MINERS JO; VALENTE L; LILLYWHITE KJ; MACKENZIE PI; BURCHELL B; BAGULEY BC; KESTELL P
      PRECLINICAL PREDICTION OF FACTORS INFLUENCING THE ELIMINATION OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, A NEW ANTICANCER DRUG

      Cancer research
    17. JIN CJ; MACKENZIE PI; MINERS JO
      THE REGIOSELECTIVITY AND STEREOSELECTIVITY OF C19 AND C21 HYDROXYSTEROID GLUCURONIDATION BY UGT2B7 AND UGT2B11

      Archives of biochemistry and biophysics
    18. SULLIVANKLOSE TH; GHANAYEM BI; BELL DA; ZHANG ZY; KAMINSKY LS; SHENFIELD GM; MINERS JO; BIRKETT DJ; GOLDSTEIN JA
      THE ROLE OF THE CYP2C9-LEU(359) ALLELIC VARIANT IN THE TOLBUTAMIDE POLYMORPHISM

      Pharmacogenetics
    19. TASSANEEYAKUL W; BIRKETT DJ; PASS MC; MINERS JO
      LIMITED VALUE OF THE URINARY PHENYTOIN METABOLIC RATIO FOR THE ASSESSMENT OF CYTOCHROME P4502C9 ACTIVITY IN-VIVO

      British journal of clinical pharmacology
    20. GRAHAM S; DAY RO; WONG H; MCLACHLAN AJ; BERGENDAL L; MINERS JO; BIRKETT DJ
      PHARMACODYNAMICS OF OXYPURINOL AFTER ADMINISTRATION OF ALLOPURINOL TOHEALTHY-SUBJECTS

      British journal of clinical pharmacology
    21. MINERS JO; BIRKETT DJ
      THE USE OF CAFFEINE AS A METABOLIC PROBE FOR HUMAN DRUG-METABOLIZING-ENZYMES

      General pharmacology
    22. TASSANEEYAKUL W; BIRKETT DJ; EDWARDS JW; VERONESE ME; TASSANEEYAKUL W; TUKEY RH; MINERS JO
      HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE

      The Journal of pharmacology and experimental therapeutics
    23. MINERS JO; COULTER S; TUKEY RH; VERONESE ME; BIRKETT DJ
      CYTOCHROME P450, 1A2, AND 2C9 ARE RESPONSIBLE FOR THE HUMAN HEPATIC O-DEMETHYLATION OF R-NAPROXEN AND S-NAPROXEN

      Biochemical pharmacology
    24. KNIGHTS KM; MCLEAN CF; TONKIN AL; MINERS JO
      LACK OF EFFECT OF GENDER AND ORAL-CONTRACEPTIVE STEROIDS ON THE PHARMACOKINETICS OF (R)-IBUPROFEN IN HUMANS

      British journal of clinical pharmacology
    25. MINERS JO; REES DLP; VALENTE L; VERONESE ME; BIRKETT DJ
      HUMAN HEPATIC CYTOCHROME-P450 2C9 CATALYZES THE RATE-LIMITING PATHWAYOF TORSEMIDE METABOLISM

      The Journal of pharmacology and experimental therapeutics
    26. TASSANEEYAKUL W; BIRKETT DJ; VERONESE ME; MCMANUS ME; TUKEY RH; MINERS JO
      DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2

      Pharmacogenetics
    27. ANDERSSON T; MINERS JO; VERONESE ME; BIRKETT DJ
      DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS

      British journal of clinical pharmacology
    28. ANDERSSON T; MINERS JO; VERONESE ME; BIRKETT DJ
      IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM

      British journal of clinical pharmacology
    29. BIRKETT DJ; REES D; ANDERSSON T; GONZALEZ FJ; MINERS JO; VERONESE ME
      IN-VITRO PROGUANIL ACTIVATION TO CYCLOGUANIL BY HUMAN LIVER-MICROSOMES IS MEDIATED BY CYP3A ISOFORMS AS WELL AS BY S-MEPHENYTOIN HYDROXYLASE

      British journal of clinical pharmacology
    30. DAY RO; BIRKETT DJ; HICKS N; MINERS JO; GRAHAM GG; BROOKS PM
      NEW USES FOR ALLOPURINOL

      Drugs
    31. ANDERSSON T; MINERS JO; BIRKETT DJ
      DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS

      Clinical pharmacology and therapeutics
    32. STOCKLEY CS; WING LMH; TONKIN AL; MINERS JO
      DISPOSITIONAL FACTORS DO NOT CONTRIBUTE TO THE ENANTIOSPECIFICITY OF THE CARDIOVASCULAR EFFECTS OF PHENYLPROPANOLAMINE

      Clinical pharmacology and therapeutics
    33. TASSANEEYAKUL W; BIRKETT DJ; MCMANUS ME; TASSANEEYAKUL W; VERONESE ME; ANDERSSON T; TUKEY RH; MINERS JO
      CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS

      Biochemical pharmacology
    34. VERONESE ME; MINERS JO; REES DLP; BIRKETT DJ
      TOLBUTAMIDE HYDROXYLATION IN HUMANS - LACK OF BIMODALITY IN 106 HEALTHY-SUBJECTS

      Pharmacogenetics
    35. ANDERSSON T; LAGERSTROM PO; MINERS JO; VERONESE ME; WEIDOLF L; BIRKETT DJ
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR HUMAN LIVER MICROSOMAL OMEPRAZOLE METABOLISM

      Journal of chromatography. Biomedical applications
    36. ANDERSSON T; MINERS JO; VERONESE ME; TASSANEEYAKUL W; TASSANEEYAKUL W; MEYER UA; BIRKETT DJ
      IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM

      British journal of clinical pharmacology
    37. JIN CJ; MINERS JO; BURCHELL B; MACKENZIE PI
      THE GLUCURONIDATION OF HYDROXYLATED METABOLITES OF BENZO[A]PYRENE AND2-ACETYLAMINOFLUORENE BY CDNA-EXPRESSED HUMAN UDP-GLUCURONOSYLTRANSFERASES

      Carcinogenesis
    38. TASSANEEYAKUL W; BIRKETT DJ; VERONESE ME; MCMANUS ME; TUKEY RH; QUATTROCHI LC; GELBOIN HV; MINERS JO
      SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2

      The Journal of pharmacology and experimental therapeutics
    39. TASSANEEYAKUL W; VERONESE ME; BIRKETT DJ; GONZALEZ FJ; MINERS JO
      VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES

      Biochemical pharmacology
    40. JIN CJ; MINERS JO; LILLYWHITE KJ; MACKENZIE PI
      CDNA CLONING AND EXPRESSION OF 2 NEW MEMBERS OF THE HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASE-2B SUBFAMILY

      Biochemical and biophysical research communications
    41. BIRKETT DJ; MACKENZIE PI; VERONESE ME; MINERS JO
      IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 22:22:25